Skip to main content
. 2011 Sep;164(1):37–47. doi: 10.1111/j.1476-5381.2011.01402.x

Figure 4.

Figure 4

Docking of the benzopyran-based inhibitors. (A) HFI-419 docked into the IRAP model. The residues are discussed above in the main text. (B) Compound HFI-437 docked into the IRAP model. The residues are discussed above in the main text. This figure is rotated 90° along the y-axis from Figure 4A.